首页> 外文期刊>Cancer: A Journal of the American Cancer Society >HNF1 beta and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies
【24h】

HNF1 beta and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies

机译:HNF1β和S100A1是有用的生物标志物,用于区分肾癌细胞瘤和致铬肾细胞癌在FNA和核心针活检中

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUNDMorphologic overlap between renal oncocytoma (RO) and chromophobe renal cell carcinoma (ChRCC) can pose diagnostic challenges, especially in biopsy samples in which tumor quantity may be limited, architectural features are not well represented, and gross examination is not possible. It has been demonstrated that immunohistochemistry (IHC) for HNF1, HNF1, and S100A1 are differentially expressed in RO and ChRCC in resection specimens. We evaluated the utility of these markers in FNA and core biopsies of RO and ChRCC.
机译:Backgroundmorphologic重叠在肾癌和致致荧光肾细胞癌(CHRCC)之间的重叠可以造成诊断挑战,特别是在哪些活组织检查样本中,其中肿瘤量可能受到限制,建筑特征不得很好地表示,并且不可能进行造型功能。 已经证明了HNF1,HNF1和S100A1的免疫组织化学(IHC)在切除试样中的RO和CHCC中差异地表达。 我们评估了这些标志物在RO和CHRCC的FNA和核心活组织检查中的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号